Immuneering Corporation

IMRX·NASDAQ·$5.27Share Price as of 11/2·$191MMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/29/26 10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/06/26 10-QQ3 ended 09/30/2511/12/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report08/05/26 8-KCurrent report06/15/26 8-KCurrent report06/11/26 8-KCurrent report06/01/26

Prospectuses and Registrations

424B5Prospectus supplement09/25/25 FWPFree writing prospectus09/25/25 424B5Prospectus supplement09/24/25 FWPFree writing prospectus09/24/25 424B3Prospectus09/08/25

Proxies

DEF 14ADefinitive proxy04/20/26 DEFA14AAdditional proxy materials04/20/26 DEF 14ADefinitive proxy04/21/25 DEFA14AAdditional proxy materials04/21/25 DEF 14ADefinitive proxy04/23/24

Ownership

Form 4Insider transaction07/17/26 Form 3Initial insider ownership07/16/26 Form 4Insider transaction06/24/26 Form 4Insider transaction06/16/26 Form 4Insider transaction06/11/26

Other

DD09/09/25 EFFECTRequest for effectiveness09/08/25 CORRESPCorrespondence with the SEC09/04/25 UPLOADLetter from the SEC09/04/25 EFFECTRequest for effectiveness08/20/25